Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).

BMJ · 2025 · PMC12570275 · PMID 41224473

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

did not reach statistical significanceP=0.087so close (0.05 < p ≤ 0.1)

For other secondary endpoints, the incidence of readmission to hospital for myocardial infarction was lower in the intervention group than in the control group, although this difference did not reach statistical significance (log-rank test, P=0.087).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.